Dataset Information

Sex-Specific Proteomic Alterations in Pattern Hair Loss: Insights into Pathogenesis and Potential Therapeutic Targets

ABSTRACT: This study presents a comprehensive comparative proteomic analysis aimed at elucidating the molecular mechanisms underlying male androgenetic alopecia (AGA) and female pattern hair loss (FPHL). Scalp samples from both AGA and FPHL patients, along with their respective normal controls, were subjected to proteomic analysis, followed by bioinformatics investigations. Our findings reveal distinct proteomic profiles between AGA and FPHL, with a total of 68 differentially expressed proteins (DEPs) identified in AGA and 84 DEPs in FPHL. Among these, specific proteins were altered in AGA and FPHL, highlighting sex-specific molecular pathways involved in the pathogenesis of pattern hair loss. Protein-protein interaction network analyses further delineated the biological processes most impacted, including cytoskeleton organization, stress response, and metabolic pathways, with particular emphasis on the differing altered stress responses and metabolic states associated with hair loss between sexes. Our study not only uncovers the complex molecular landscape of AGA and FPHL but also identifies potential biomarkers and therapeutic targets, offering new insights into the sex-specific pathogenesis of pattern hair loss

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Keratinocyte

DISEASE(S): Disease Free

SUBMITTER: Poorichaya Somparn

LAB HEAD: poorichaya somparn

PROVIDER: PXD052630 | Pride | 2026-06-23

REPOSITORIES: pride

ACCESS DATA

Similar Datasets

Project description:Background Androgenetic alopecia (AGA), the most prevalent form of hair loss, is driven by the dysfunction of dermal papilla cells (DPCs). Emerging evidence implicates DPC senescence in the pathogenesis of AGA; however, the underlying molecular mechanisms remain incompletely elucidated.Methods We employed a multi-faceted experimental approach, including analyses of human scalp tissues, primary DPCs, a dihydrotestosterone (DHT)-induced AGA mouse model, and immortalized DPCs stimulated with DHT. Cellular senescence was evaluated via expression of senescence markers (p16INK4a, p21, p53) and senescence-associated β-galactosidase staining. Cell proliferation, migration, and apoptosis were also assessed. Mitochondrial function was evaluated using transmission electron microscopy, MitoTracker, MitoSOX, JC-1, and Seahorse assays. RNA sequencing and bioinformatics analyses were performed to identify differentially expressed genes. The interaction between Aconitate Decarboxylase 1 (ACOD1) and DDX1 was verified via co-immunoprecipitation, mass spectrometry, and molecular docking. Metabolomic analysis was performed to profile intracellular metabolic alterations. Functional experiments included ACOD1 knockdown/overexpression and exogenous supplementation with 4-octyl itaconate (4-OI). Hair follicle morphology and hair loss in AGA mice were evaluated following 4-OI treatment.Results Senescence markers were significantly elevated in AGA DPCs, accompanied by increased senescence-associated β-galactosidase staining, reduced cell proliferation and migration, and enhanced apoptosis. DHT-induced mitochondrial dysfunction in DPCs was characterized by increased mitochondrial fragmentation, decreased mitochondrial cristae, superoxide accumulation, reduced membrane potential, and impaired oxidative phosphorylation. RNA sequencing identified ACOD1 as significantly downregulated in DHT-treated DPCs. ACOD1 knockdown induced mitochondrial dysfunction, cellular senescence, and functional impairment in DPCs, while ACOD1 overexpression rescued these DHT-induced phenotypes. Mechanistically, ACOD1 interacted with DDX1 to inhibit its methylation; ACOD1 knockdown enhanced DDX1 methylation, thereby promoting mitochondrial dysfunction and DPC senescence. Metabolomic analysis demonstrated that ACOD1 knockdown significantly reduced itaconate levels. Exogenous 4-OI supplementation reduced DDX1 methylation, ameliorated DHT-induced mitochondrial dysfunction and cellular senescence, promoted cell proliferation and migration, suppressed apoptosis, mitigated hair follicle miniaturization, and alleviated hair loss in AGA mice.Conclusions Our findings reveal a novel mechanism underlying DPC senescence in AGA, wherein ACOD1 deficiency promotes DDX1 methylation, mitochondrial dysfunction, and subsequent DPC senescence. ACOD1 represents a promising therapeutic target for AGA, and 4-OI may have translational potential for the treatment of AGA.

Project description:Although regulation of energy metabolism has been linked with multiple disorders, its role in depression and responsiveness to antidepressants is less-known. We found that an epigenetic and energetic agent, acetyl-L-carnitine (LAC, oral administration), rapidly rescued the depressive- and central and systemic metabolic-like phenotype of LAC-deficient Flinders Sensitive Line (FSL) rats. After acute stress during LAC treatment, a subset of FSL continued to respond to LAC (rFSL), whereas the other subset did not respond (nrFSL). RNAseq for the ventral dentate-gyrus (vDG), a mood-regulatory region, identified metabolic factors as key markers predisposing to depression (insulin receptors Insr, glucose transporters Glut-4 and Glut-12, the regulator of appetite Cartpt) and to LAC responsiveness (leptin receptors Lepr, metabotropic glutamate receptors-2 mGlu2, neuropeptide-Y NPY, and mineralocorticoid receptors MR). Furthermore, we found that stress-induced treatment-resistance in nrFSL shows a new gene profile, including the metabolic regulator factors Elovl7 and Cyb5r2 and the synaptic regulator NPAS4. Finally, while improving central energy regulation and exerting rapid antidepressant-like effects, LAC corrected a systemic hyperinsulinemia and hyperglycemia.tance in rFSL and failed to do that in nrFSL. These findings establish CNS energy regulation as factor to be considered for the development of better therapeutics. Agents, like LAC, which regulate metabolic factors and reduce glutamate overflow, could rapidly ameliorate depression and could also be considered for treatment of insulin-resistance in depressed subjects. The approach here serves as a model for identifying markers and underlying mechanisms of predisposition to diseases and treatment responsiveness that may be useful in translation to human behavior and psychopathology. Ventral dentate gyrus RNA from 3 biological replicates per group (vehicle-FRL, vehicle-FSL, LAC-treated not-responder FSL, LAC-treated responder FSL, all males) was used for library prep (TruSeq Stranded Total RNA with Ribo-Zero Human/Mouse/Rat) and sequenced on Illumina HiSeq2500 at the Genomic Core facility at The Rockefeller University. Each sample was provided with a unique adapter and all samples were put in the same pool and run in multiple lanes to control for lane effects with a sequencing depth of about 30M (100bp, single).

			Action	DRS
	FA1.mgf	Mgf
	FA1.msf	Msf
	FA1.raw	Raw
	FA2.mgf	Mgf
	FA2.msf	Msf

Dataset Information

Sex-Specific Proteomic Alterations in Pattern Hair Loss: Insights into Pathogenesis and Potential Therapeutic Targets

Dataset's files

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets